About Daktari Diagnostics
Daktari Diagnostics is a Healthcare company based in Boston (United States) founded in 2008. Point of care diagnostic platform and data management system. Daktari Diagnostics has raised $73.42 million across 15 funding rounds from investors including NIH, HHS and NIAID. The company has 23 employees. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Viral. Its legal entity is DAKTARI DIAGNOSTICS INC. Its competitors include Senzo, Hememics Biotechnologies and Quantalife; 3 of its 3 listed competitors have raised funding.
Company details
Daktari Diagnostics was founded in 2008 in Boston, United States, within the diagnostics sector. A portable point-of-care diagnostic platform with wireless connectivity and a cloud-based data management system is provided. Offerings include Daktari Virology for HCV and HIV detection, Daktari InSight for connecting systems to customers, and Daktari Sickle Cell for identifying infants with sickle cell disease. A partnership with Merck Co for Hepatitis C was announced.
- Headquarters Boston, United States
- Employees 23
- SectorsHealthcare
- Website daktaridx.com
- Social LinkedIn X Facebook
- Legal Name Daktari Diagnostics Inc.
- Total Equity Funding$73.42M (USD)
in 15 rounds
- Latest Funding Round$221.65K (USD), Grant
May 2017
- InvestorsNIH
& 11 more
- Employee Count23
Funding Insights of Daktari Diagnostics
Daktari Diagnostics has successfully raised a total of $73.42M across 15 strategic funding rounds. The most recent funding activity was a Grant round of $221.65 thousand completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $73.42M
- Total Rounds 15
- Last Round Grant — $221,653
- First Round $2.8M
(Sep 2009)
- Investors Count 12
Latest 10 of 15 funding rounds of Daktari Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2017 | $221,653 | Grant | – | – | |
| Dec 2016 | $1.3M | Grant | – | – | |
| Jul 2016 | $649,571 | Grant | – | – | |
| May 2016 | $22.5M | Series D | – | Eastern Capital, Merck Global Health Innovation Fund | |
| Mar 2015 | $15.5M | Series D | – | Eastern Capital, Merck Global Health Innovation Fund | |
| Aug 2014 | $413,140 | Grant | – | – | |
| Jun 2014 | Grant | – | – | ||
| Jun 2014 | $1.35M | Grant | – | – | |
| Apr 2014 | $20M | Series C | – | – | – |
| Mar 2014 | $2.68M | Grant | – | – | – |
12 investors in total: 12 institutional.
Investors in Daktari Diagnostics
Daktari Diagnostics has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and NIAID.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital is focused on the life science sector. | merckghifund.com | Kenilworth, United States | ||
| norwichventures.com | ||||
Investments are provided by an angel network to Boston-based companies. | launchpadventuregroup.com | Newton, United States | ||
Angel Network for companies based in Boston | hubangels.com | Boston, United States | ||
Angel investing services are provided to early-stage startups. | 2004 | bostonharborangels.com | Boston, United States | |
Seed stage investments are made in life sciences and healthcare. | 2010 | massmedangels.com | Boston, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| niaid.nih.gov | ||||
| partners.org | ||||
| easterncapital.com |
Investor details for Daktari Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Daktari Diagnostics
1 people are tracked at Daktari Diagnostics (1 in team); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Thierry Bernard | Board Member | Team |
Complete people profiles for Daktari Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Daktari Diagnostics
3 dated milestones of Daktari Diagnostics across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Daktari Diagnostics is founded.
- Funding First funding round of $2.8M.
- Funding Latest funding round, Grant, of $222K.
Competitors of Daktari Diagnostics
Daktari Diagnostics has 3 listed competitors in our database, 3 of them funded. They include Senzo, Hememics Biotechnologies and Quantalife.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| senzo.com | 2013 | San Francisco, United States | $9.6M | 13 | Point-of-care diagnostic devices for infectious diseases are developed. | |
| hememics.com | 2009 | Gaithersburg, United States | $4.6M | 13 | Biopreservation platform for mammalian cells and biologics is developed. | |
| quantalife.com | 2008 | Pleasanton, United States | $28.71M | Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. |
Detailed competitors of Daktari Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Daktari Diagnostics (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Daktari Diagnostics
Daktari Diagnostics was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Daktari Diagnostics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Daktari Diagnostics is a funded company, having raised a total of $73.42M across 15 funding rounds to date. The company's 1st funding round was a Grant of $2.68M, raised on Sep 2009.
Daktari Diagnostics has 23 employees.
Daktari Diagnostics was founded in 2008 in Boston, United States, within the diagnostics sector. A portable point-of-care diagnostic platform with wireless connectivity and a cloud-based data management system is provided. Offerings include Daktari Virology for HCV and HIV detection, Daktari InSight for connecting systems to customers, and Daktari Sickle Cell for identifying infants with sickle cell disease. A partnership with Merck Co for Hepatitis C was announced.
Daktari Diagnostics's top competitors include Quantalife, Senzo and Hememics Biotechnologies.
Daktari Diagnostics operates through Daktari Diagnostics Inc..